Travere Therapeutics Announces Positive Topline Results : vi

Data from the four patients treated with the highest dose of pegtibatinase showed a clinically meaningful 67.1% mean relative reduction in total...

Related Keywords

Philadelphia , Pennsylvania , United States , Naomi Eichenbaum , Nivi Nehra , Nasdaq , Corporate Communications , Travere Therapeutics Inc , Exchange Commission , William Rote , Clinical Director , Metabolic Disease Program , Relative Reduction , Geometric Mean , Total Homocysteine , Breakthrough Therapy , Rare Pediatric Disease , Fast Track , Orphan Drug , Travere Therapeutics , Private Securities Litigation Reform Act , Nasdaq Tvtx , Nc , Egtibatinase , Classical Homocystinuria , Homocysteine , Ethionine ,